Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology

Long-Term Monitoring and Survivorship

At a Glance

Long-term survivorship for Autosomal Recessive Cerebellar Ataxia (ARCA) requires proactive, routine monitoring. Key priorities include heart evaluations for FRDA, strict radiation avoidance and cancer screenings for A-T, and consistent bone and mental health support.

Living with an Autosomal Recessive Cerebellar Ataxia (ARCA) is a marathon, not a sprint. While the primary symptoms of ataxia involve the brain and balance, long-term care—often called “survivorship”—focuses on proactively protecting the rest of your body [1][2].

Protecting Your Heart

In several types of ARCA, the heart muscle can be affected even before walking issues become severe.

  • Friedreich’s Ataxia (FRDA): Hypertrophic cardiomyopathy (a thickening of the heart muscle) affects approximately 60% of people with FRDA and is a primary driver of long-term health risks [3][4]. Regular screening with echocardiograms (heart ultrasounds) and EKGs is mandatory to monitor heart function and detect irregular rhythms early [5][6].

Specialized Screening for Ataxia-Telangiectasia (A-T)

Because the genetic change in A-T affects how the body repairs DNA, patients have unique, critical long-term needs [7].

  • CRITICAL SAFETY WARNING - Radiation Sensitivity: Patients with A-T have a severe sensitivity to ionizing radiation. It is absolutely critical to avoid unnecessary X-rays and CT scans. These can cause severe cellular damage and trigger malignancies. Always ensure any doctor treating you knows about this strict limitation [8].
  • Cancer Surveillance: People with A-T have an increased risk of certain cancers, like leukemia and lymphoma [9]. While this sounds terrifying, modern care involves highly standardized, preventative protocols designed to keep patients safe. This usually involves regular, routine blood work and sometimes annual, radiation-free imaging (like Whole-Body MRI) so that any issues are caught and managed as early as possible [10][11].
  • Respiratory Health: Protecting the lungs from chronic infections is vital. Management includes proactive monitoring and physical therapy to help clear airways [12][13].

Bone and Orthopedic Health

Maintaining a strong “foundation” for your body is a major part of long-term ARCA management.

  • Bone Density: Many patients with FRDA have low bone mineral density, increasing the risk of fractures [14]. Specialists often recommend DEXA scans to monitor bone health [14].
  • Scoliosis: Curvature of the spine (scoliosis) is common in early-onset ataxias [15]. Regular orthopedic check-ups are necessary to ensure that any spinal changes do not interfere with sitting or breathing [16].

Managing the Psychological Journey

The burden of a progressive disease and the “scan anxiety” that comes with regular monitoring are significant emotional challenges [17][18].

  • Scan Anxiety: It is entirely normal to feel distress before your routine imaging results. Having clear, pre-scan information and a support system in place can help reduce this anxiety [19][20].
  • Integrated Support: Mental health screening and counseling should be a standard part of your multidisciplinary care team, rather than an afterthought [21][22].

A Proactive Approach

While the diagnosis of a progressive condition is heavy, being “proactive rather than reactive” changes the narrative [23]. By attending regular screenings and managing complications early, you and your care team can focus on the ultimate goal: maximizing your function and independence for as long as possible [13][5].

Return to the main index: Return to Home Page

Common questions in this guide

Why do I need heart screenings if I have Friedreich's Ataxia (FRDA)?
In FRDA, the heart muscle can thicken, leading to a condition called hypertrophic cardiomyopathy. Regular echocardiograms and EKGs are essential to monitor heart function and detect irregular rhythms before they become severe.
Why should I avoid X-rays if I have Ataxia-Telangiectasia (A-T)?
Patients with A-T have a severe sensitivity to ionizing radiation because their bodies struggle to repair DNA damage. It is critical to avoid unnecessary X-rays and CT scans to prevent cellular damage and reduce the risk of developing cancer.
How do doctors monitor bone health in ataxia patients?
Many patients with early-onset ataxias are at risk for low bone density and spinal curvature (scoliosis). Doctors typically monitor this using DEXA scans to check bone strength and regular orthopedic check-ups to track spinal health.
What is scan anxiety and how is it managed?
Scan anxiety is the emotional distress or worry experienced before undergoing routine medical imaging or receiving test results. This is completely normal, and working with a counselor or therapist can help you develop strategies to manage these feelings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often should I have an echocardiogram and EKG to monitor for heart changes? (especially if I have FRDA or COQ8A-related ataxia).
  2. 2.Can we schedule a baseline DEXA scan to check my bone density?
  3. 3.If I have A-T, what specific preventative, radiation-free protocols are we using to monitor my cancer and lung risks?
  4. 4.Are there specific 'red flag' symptoms I should watch for that indicate a non-neurological complication is starting?
  5. 5.Can you refer me to a therapist or counselor who specializes in the psychological impact of chronic, progressive illness?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Friedreich Ataxia: Multidisciplinary Clinical Care.

    Lynch DR, Schadt K, Kichula E, et al.

    Journal of multidisciplinary healthcare 2021; (14()):1645-1658 doi:10.2147/JMDH.S292945.

    PMID: 34234452
  2. 2

    Effectiveness of rehabilitation intervention in persons with Friedreich ataxia.

    Paparella G, Stragà C, Vavla M, et al.

    Frontiers in neurology 2023; (14()):1270296 doi:10.3389/fneur.2023.1270296.

    PMID: 38020600
  3. 3

    Omaveloxolone: potential new agent for Friedreich ataxia.

    Lynch DR, Johnson J

    Neurodegenerative disease management 2021; (11(2)):91-98 doi:10.2217/nmt-2020-0057.

    PMID: 33430645
  4. 4

    Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes.

    Angulo MB, Bertalovitz A, Argenziano MA, et al.

    Molecular genetics & genomic medicine 2023; (11(1)):e2093 doi:10.1002/mgg3.2093.

    PMID: 36369844
  5. 5

    Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia.

    Monda E, Lioncino M, Rubino M, et al.

    Heart failure clinics 2022; (18(1)):31-37 doi:10.1016/j.hfc.2021.07.001.

    PMID: 34776081
  6. 6

    Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study.

    Indelicato E, Reetz K, Maier S, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(3)):510-518 doi:10.1002/mds.29687.

    PMID: 38140802
  7. 7

    Absence of ATM leads to altered NK cell function in mice.

    Covino DA, Desimio MG, Giovinazzo A, et al.

    Clinical immunology (Orlando, Fla.) 2024; (263()):110233 doi:10.1016/j.clim.2024.110233.

    PMID: 38697554
  8. 8

    The spectrum of ATM gene mutations in Iranian patients with ataxia-telangiectasia.

    Amirifar P, Ranjouri MR, Pashangzadeh S, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2021; (32(6)):1316-1326 doi:10.1111/pai.13461.

    PMID: 33547824
  9. 9

    Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany.

    Dutzmann CM, Spix C, Popp I, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022; (40(1)):32-39 doi:10.1200/JCO.21.01495.

    PMID: 34597127
  10. 10

    Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review.

    Sabino Pinho de Oliveira B, Putti S, Naro F, Pellegrini M

    Cancers 2020; (12(11)) doi:10.3390/cancers12113207.

    PMID: 33142696
  11. 11

    Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.

    Petralia G, Koh DM, Attariwala R, et al.

    Radiology 2021; (299(3)):494-507 doi:10.1148/radiol.2021201740.

    PMID: 33904776
  12. 12

    ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia.

    Bhatt JM, Bush A, van Gerven M, et al.

    European respiratory review : an official journal of the European Respiratory Society 2015; (24(138)):565-81 doi:10.1183/16000617.0066-2015.

    PMID: 26621971
  13. 13

    Clinical complications and their management in a child with ataxia-telangiectasia (A-T): A case report study.

    Heidarzadeh Arani M, ArefNezhad R, Fathgharib J, et al.

    Clinical case reports 2021; (9(1)):556-559 doi:10.1002/ccr3.3581.

    PMID: 33505696
  14. 14

    Bone Mineral Density and Current Bone Health Screening Practices in Friedreich's Ataxia.

    Dunn J, Tamaroff J, DeDio A, et al.

    Frontiers in neuroscience 2022; (16()):818750 doi:10.3389/fnins.2022.818750.

    PMID: 35368287
  15. 15

    Scoliosis Surgery in a Patient With Advanced Friedreich's Ataxia-It Is Not Too Late.

    Reetz K, Lischewski SA, Schulz JB, et al.

    Annals of clinical and translational neurology 2026; (13(1)):200-203 doi:10.1002/acn3.70219.

    PMID: 41044041
  16. 16

    Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort.

    Rummey C, Flynn JM, Corben LA, et al.

    Annals of clinical and translational neurology 2021; (8(6)):1239-1250 doi:10.1002/acn3.51352.

    PMID: 33949801
  17. 17

    Evaluating participant experiences and tolerability with MR Linac imaging.

    Nartey J, McNair HA, Biscombe K, et al.

    Technical innovations & patient support in radiation oncology 2025; (36()):100348 doi:10.1016/j.tipsro.2025.100348.

    PMID: 41143281
  18. 18

    Survey of maternal anxiety and perceptions towards foetal MRI and pre-scan education.

    Plunkett S, Dobeli K, Prior M, Tusek X

    Journal of medical radiation sciences 2024; (71(1)):10-20 doi:10.1002/jmrs.725.

    PMID: 37724764
  19. 19

    Effects of a 360° virtual counselling environment on patient anxiety and CCTA process time: A randomised controlled trial.

    Paalimäki-Paakki K, Virtanen M, Henner A, et al.

    Radiography (London, England : 1995) 2023; (29 Suppl 1()):S13-S23 doi:10.1016/j.radi.2022.09.013.

    PMID: 36280541
  20. 20

    The experience of patients participating in a small randomised control trial that explored two different interventions to reduce anxiety prior to an MRI scan.

    Tugwell-Allsup J, Pritchard AW

    Radiography (London, England : 1995) 2018; (24(2)):130-136 doi:10.1016/j.radi.2017.11.001.

    PMID: 29605109
  21. 21

    Prevalence and predictive factors of psychological morbidity following facial injury: a prospective study of patients attending a maxillofacial outpatient clinic within a major UK city.

    Wilson N, Heke S, Holmes S, et al.

    Dialogues in clinical neuroscience 2018; (20(4)):327-339.

    PMID: 30936771
  22. 22

    Global availability and uptake of psychological services for adults, caregivers and children with food allergy.

    Knibb RC, Herbert LJ, Jones CJ, et al.

    Allergy 2024; (79(10)):2787-2797 doi:10.1111/all.16204.

    PMID: 39031702
  23. 23

    Ataxia-telangiectasia: recommendations for multidisciplinary treatment.

    van Os NJH, Haaxma CA, van der Flier M, et al.

    Developmental medicine and child neurology 2017; (59(7)):680-689 doi:10.1111/dmcn.13424.

    PMID: 28318010

This page provides general educational information about long-term care and monitoring for ARCA. Always consult your multidisciplinary healthcare team for personalized screening protocols and medical advice.

Get notified when new evidence is published on Autosomal recessive cerebellar ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.